Evidence map›Paper›PMID 22808179›Full record

ArticlePloS one2012

Prognostic significance of elevated cardiac troponin-T levels in acute respiratory distress syndrome patients.

Matthew B Rivara, Ednan K Bajwa, James L Januzzi, Michelle N Gong, B Taylor Thompson, David C Christiani

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. COVID-19 Pandemic: Cardiovascular Complications and Future Implications.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2020
    Review
  12. Review
  13. Review
  14. Review
  15. Observational
  16. Article
  17. Prognostic factors in the acute respiratory distress syndrome.Clinical and translational medicine · 2015
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Matthew B RivaraDepartment of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Ednan K Bajwa
James L Januzzi
Michelle N Gong
B Taylor Thompson
David C Christiani
Massachusetts General Hospital · USHarvard University · USMontefiore Medical Center · US

Funding

MOLECULAR EPIDEMIOLOGY OF ARDSR01HL060710 · NHLBI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 2000 to 2015
$8.4M
TRAINING GRANT IN LUNG CELL &MOLECULAR BIOLOGYT32HL007874 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MEDOFF, BENJAMIN DAVID · 1997 to 2011
$4.1M
Molecular Epidemiology of ARDS and Septic ShockK23HL067197 · NHLBI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI GONG, MICHELLE NG · 2001 to 2005
$650k
NHLBI NIH HHS HL07874NHLBI NIH HHS HL60710NHLBI NIH HHS HL67197NHLBI NIH HHS K23 HL067197NHLBI NIH HHS R01 HL060710NHLBI NIH HHS T32 HL007874
6 · The paper itself

Abstract

backgroundElevated levels of biochemical markers of myocardial necrosis have been associated with worsened outcomes in Acute Respiratory Distress Syndrome (ARDS), but there are few prospective data on this relationship. We investigated elevated cardiac troponin T (cTnT) levels and their relationship with outcome in patients with ARDS.

methodsA prospective cohort study of patients with ARDS was conducted at a tertiary-care academic medical center. Patients had blood taken within 48 hours of ARDS onset and assayed for cTnT. Patients were followed for the outcomes of 60-day mortality, number of organ failures, and days free of mechanical ventilation. Echocardiographic and electrocardiographic (ECG) data were analyzed for signs of myocardial ischemia, infarction, or other myocardial dysfunction.

results177 patients were enrolled, 70 of whom died (40%). 119 patients had detectable cTnT levels (67%). Median cTnT level was 0.03 ng/mL, IQR 0-0.10 ng/mL, and levels were higher among non-survivors (P = .008). Increasing cTnT level was significantly associated with increasing mortality (P = .008). The association between increasing cTnT level and mortality remained significant after adjustment in a multivariate model (HR(adj) = 1.45, 95% CI 1.17-1.81, P = .001). Elevated cTnT level was also associated with increased number of organ failures (P = .002), decreased number of days free of mechanical ventilation (P = .03), echocardiographic wall motion abnormalities (P = 0.001), and severity of tricuspid regurgitation (P = .04). There was no association between ECG findings of myocardial ischemia or infarction and elevated cTnT.

conclusionsElevated cTnT levels are common in patients with ARDS, and are associated with worsened clinical outcomes and certain echocardiographic abnormalities. No association was seen between cTnT levels and ECG evidence of coronary ischemia.

Indexed as

AdultAgedBiomarkersFemaleHumansMaleMiddle AgedMyocardiumPrognosisProportional Hazards ModelsRespiratory Distress SyndromeSurvival AnalysisTime FactorsTreatment OutcomeTroponin TUltrasonographyBiomarkersTroponin T

Identifiers

PMID22808179
PMCPMC3395687
OpenAlexW2131168179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.